期刊文献+

肝硬化患者血清IGF-Ⅰ、脂联素和HA测定及其临床意义 被引量:4

Clinical Significance of Determination of Serum IGF-Ⅰ,Adiponectin and HA Levels in Patients with Hepatic Cirrhosis
下载PDF
导出
摘要 目的:探讨肝硬化患者血清中胰岛素样生长因子-Ⅰ(IGF-Ⅰ)、脂联素和透明质酸(HA)的关系及临床意义。方法:应用放射免疫分析对178例肝硬化患者进行血清IGF-Ⅰ、脂联素和HA含量测定,同时设60名健康体检者为正常对照组。结果:肝硬化患者血清IGF-Ⅰ、脂联素水平较正常组显著降低(P<0.01,P<0.05),而HA水平明显升高,且二者与HA水平呈负相关(r=-0.737、-0.692,P<0.01)。结论:检测血清IGF-Ⅰ、脂联素和HA水平对判断病情的轻重和预后观察均具有重要的临床价值。 Objective To investigate the significance of changes of serum IGF - Ⅰ , adiponectin and HA contents in patients with hepatic cirrhosis. Methods Serum IGF - Ⅰ , adiponectin and HA levels were measured with RIA in 178 patients with cirrhosis and 60 controls. Results The serum level of IGF - Ⅰ and adiponectin were significantly lower in the patients than those in controls (P 〈 0. 01, P 〈 0. 05), while the serum HA level was significantly higher. Conclusion Detection of serum IGF - Ⅰ, adiponectin and HA levels is valuble for the diagnosis, assessment of the disease process and outcome prediction in patients with cirrhosis.
出处 《放射免疫学杂志》 CAS 2007年第6期540-542,共3页 Journal of Radioimmanology
关键词 肝硬化 胰岛素样生长因子-Ⅰ 脂联素 透明质酸(HA) cirrhosis, insulin-like growth factor- Ⅰ (IGF- Ⅰ ), adiponectin, hyaluronic acid(HA)
  • 相关文献

参考文献6

  • 1Nonaka H,TsajinoT,Watari Y,et al. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: a melioration of homocysteine-induond endoplasmic reticulum stress by taurine. Circulation. 2001,10(4) :1165.
  • 2Mujumdar VS,Aru GM,Tyagi SC,et al. Induction of oxidative stress by homocysteine impairs endothelial function. J Cell Biochem. 2001,82 (3) :491.
  • 3Musso G,Gambino R, Biroll G, et al. Hypoadiponeetinemia predicts the severity of hepatic fibrosis and pancreatic Beta - cell dysfunction in nondiabetic nonobese patients with non-alcoholic steatohepatitls. Am J Gastroenterol, 2005,100( 11 ) :2438.
  • 4Jonson J-R, Moschen A,Hickman J, et al. Adiponectin and its receptara in patients with chronic hepatitis C. J Hepatol. 2005,43(6) :929.
  • 5Kaser S,Moschen A,Kaser A, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Int Med. 2005,258(3):274.
  • 6Ding X, Saxena NK, Lin S, et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and atellate cell biology. Am J Pathol. 2005,166(6) :1655.

同被引文献42

  • 1吴剑华.内源性一氧化氮与肝硬变[J].国外医学(流行病学.传染病学分册),1995,22(4):156-160. 被引量:12
  • 2吴家明.肝硬化患者血浆Hcy检测的临床意义[J].放射免疫学杂志,2006,19(2):152-154. 被引量:6
  • 3陶志强.肝硬化患者血清sIL-2R和T淋巴细胞亚群水平的探讨[J].放射免疫学杂志,2006,19(3):244-245. 被引量:7
  • 4Fattly Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].实用肝脏病杂志,2007,10(1):1-3. 被引量:144
  • 5薛辉,颜光涛,林季.IGF-Ⅰ RIA的建立及初步应用[J].放射免疫学杂志,2007,20(2):97-98. 被引量:4
  • 6KAMADA Y, TAMURA S, KISO S, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin [J]. Gas2troenterology ,2003, 125: 1796-1807.
  • 7CHUANG JH, WANG PW, TAI MH. An adipocentric view of liver fibrosis and cirrhosis[J]. Chang Gung Med J, 2004, 27: 855-868.
  • 8DING X, SAXENA NK, LIN S, et al. The roles of leptin and adiponectin :anovel paradigm in adipocytokine regallation of liver fibrosis and stellatecell biology[J]. And Pathol,2005, 166(6): 1655-1669.
  • 9MASAKI T, CHIBA S, TATSUKAWA H, et al. Adiponectin protects LPS-indueed liver injury through modulation of TNF-alpha in KK-Ay obese mice[J]. Hepatology ,2004, 40(1): 177-184.
  • 10WOLF AM, WOLF D, AVILA MA, et al. Up-regulation of the anti-inflammatory adipokine adiponetin in acute liver failure inmice[J]. J Hepatol,2006, 44(3): 537-543.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部